1. What is the future for fluoride in the treatment of osteoporosis?

   • J. D. Ringe
   • P. J. Meunier

   Editorial Pages: 71 - 74

2. Evaluation of therapeutic efficacy in osteoporosis

   • S. Adami
   • S. Ortolani
   • R. Wasnich

   Review Article Pages: 75 - 78

3. A review of the recent advances in magnetic resonance imaging in the assessment of osteoporosis

   • S. Majumdar
   • H. K. Genant

   Review Article Pages: 79 - 92

4. Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretion

   • J. O. Landman
   • S. E. Papapoulos

   Original Article Pages: 93 - 96

5. Caffeine and the calcium economy revisited

   • M. J. Barger-Lux
   • R. P. Heaney

   Original Article Pages: 97 - 102

6. Calciotropic hormones in elderly people with and without hip fracture

   • C. L. Benhamou
   • D. Tourliere
   • P. Jallet

   Original Article Pages: 103 - 107

7. Monofluorophosphate increases lumbar bone density in osteopenic patients: A double-masked randomized study

   • J. L. Sebert
   • P. Richard
   • G. Loeb

   Original Article Pages: 108 - 114

8. Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects

   • M. W. Lundy
   • M. Stauffer
   • B. L. Riggs

   Original Article Pages: 115 - 129

9. Calcaneal ultrasonic measurements discriminate hip fracture independently of bone mass

   • C. H. Turner
   • M. Peacock
   • C. C. Johnston Jr.

   Original Article Pages: 130 - 135

10. Cost-effectiveness of fracture prevention in established osteoporosis

    • B. Jönsson
    • C. Christiansen
    • J. Hedbrandt

    Original Article Pages: 136 - 142